After analyzing 218 patients with MDS with ring sideroblasts ≥5%, investigators suggested SF3B1-unmutated MDS-RS as a distinct entity to the mutant counterpart characterized by increased prevalence of MDS with excess blasts, complex karyotype, lower peripheral blood counts, and TP53 mutation. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.